• HRP Goat Anti-Rabbit IgG (H+L) Antibody: Protocol & QC Guide

  2026-06-09

  The HRP Goat Anti-Rabbit IgG (H+L) Antibody (SKU K1223) addresses the need for high-specificity, low-background secondary antibody detection in immunoassays targeting rabbit primary antibodies. It is optimized for research use in workflows like Western blot, ELISA, and IHC, but is not suitable for diagnostic or medical applications.

• Hoechst 33342 Nuclear Stain: Advancing Senescence Research

  2026-06-09

  Explore how Hoechst 33342 Solution (1 mg/mL) empowers next-generation studies of cellular senescence, mitochondrial quality, and anti-aging interventions. This article connects mechanistic insights from pterostilbene research in dermal fibroblasts to strategic guidance for translational teams, highlighting protocol parameters and competitive advantages for live and fixed cell nuclear staining in advanced microscopy and flow cytometry.

• 2-NBDG for Dynamic Glucose Metabolism Assays: Insights & Inn

  2026-06-08

  Explore the advanced use of 2-NBDG as a fluorescent glucose uptake tracer, uniquely focusing on its mechanistic integration with metabolic signaling and disease modeling. This article delivers actionable scientific depth for researchers optimizing glucose metabolism assays.

• Dynamic Lipid Nanoparticles Enable CRISPR-Cas9 Editing for C

  2026-06-08

  Cao et al. introduce dynamically covalent lipid nanoparticles (LNPs) that deliver Cas9 mRNA and sgRNA for targeted VEGFA gene editing in choroidal neovascularization (CNV). Their approach demonstrates efficient, minimally immunogenic genome editing and sustained therapeutic efficacy, offering a nonviral alternative to current CNV treatments.

• Hyaluronic Acid-Enhanced ECM Sponges for Diabetic Wound Heal

  2026-06-07

  This study introduces a multifunctional sponge scaffold integrating hyaluronic acid, acellular dermal matrix, and polydopamine nanoparticles for diabetic wound healing. By leveraging photothermal warm bath therapy and sustained deferoxamine release, the scaffold significantly improves angiogenesis and accelerates tissue repair, highlighting a promising strategy for chronic wound management.

• Hoechst 33342 Solution (1 mg/mL): Reliable Nuclear Stain for

  2026-06-06

  This article explores real-world laboratory scenarios highlighting the practical and scientific strengths of Hoechst 33342 Solution (1 mg/mL) (SKU K2407). Through evidence-backed Q&As, it demonstrates how this reagent from APExBIO supports reproducible, sensitive, and workflow-friendly nuclear staining for cell viability, proliferation, and cytotoxicity assays. Key considerations in protocol design, data interpretation, and vendor selection are addressed.

• Endogenous H2S Deficiency and ER Stress in Diabetic Cardiomy

  2026-06-05

  This study uncovers a mechanistic link between reduced endogenous hydrogen sulfide (H2S) production and increased endoplasmic reticulum (ER) stress in the development of diabetic cardiomyopathy (DCM). Through integrated clinical, animal, and cell-based experiments, the authors demonstrate that restoring H2S levels can mitigate myocardial injury, highlighting ER stress as a pivotal therapeutic target in DCM.

• Bacitracin (B1670): Protocol and Workflow Guide for Antibact

  2026-06-05

  Bacitracin is a peptide antibiotic used to disrupt bacterial cell wall synthesis, supporting antibacterial research targeting both gram-positive and gram-negative bacteria. It is strictly intended for laboratory workflows and is unsuitable for diagnostic or medical applications. Researchers should adhere to detailed protocol and handling guidelines for reliable results.

• CFDA SE Cell Tracer Kit: Technical Guide for Cell Tracking S

  2026-06-04

  The CFDA SE (carboxyfluorescein diacetate succinimidyl ester) Cell Tracer Kit provides a stable, covalent method for long-term cell labeling, critical for cell proliferation and lineage tracing workflows. It is not suitable for short-term, reversible, or dynamic studies requiring rapid dye clearance.

• BMAL1 Phase Separation Orchestrates Circadian Transcription

  2026-06-04

  Gao et al. demonstrate that BMAL1, a core circadian clock protein, forms dynamic nuclear condensates through phase separation, a process dependent on its intrinsically disordered region and regulated by phosphorylation. This discovery provides a mechanistic explanation for the temporal regulation of circadian gene expression and underpins new approaches for the study of post-translational modifications in circadian biology.

• Neurogenetic Gradients of Nurr1+ Neurons in Rat Claustrum De

  2026-06-03

  Fang et al. (2021) provide a detailed developmental and neurogenetic analysis of Nurr1 positive neurons in the rat claustrum and adjacent lateral cortex. Their findings clarify the timing, patterning, and gradients of these neurons' genesis, resolving longstanding ambiguities in claustral development and offering new benchmarks for neuroanatomical research.

• PD 173074 (A8253): Reliable FGFR1/VEGFR2 Inhibition in Cell

  2026-06-03

  This article provides scenario-driven, evidence-based guidance for using PD 173074 (SKU A8253) in cell viability and proliferation workflows targeting FGFR/VEGFR signaling. By integrating recent literature and real-world laboratory challenges, we highlight how PD 173074 offers reproducible, selective inhibition and practical protocol optimization for biomedical researchers.

• Pharmacogenomics of Chloroquine/Hydroxychloroquine: Systemat

  2026-06-02

  This systematic review synthesizes current pharmacogenomic evidence for chloroquine and hydroxychloroquine, highlighting how genetic variability in CYP2C8, CYP3A4/5, and CYP2D6 affects drug safety and efficacy. Its findings provide clinicians and researchers with a framework for predicting risk phenotypes and underscore the need for genotype-guided therapy in diverse patient populations.

• THBS1 as a Prognostic Marker and Lipid Regulator in Laryngea

  2026-06-02

  A recent integrative analysis identified THBS1 as a key prognostic biomarker with therapeutic vulnerability in laryngeal cancer. The study links THBS1 expression to immune suppression and dysregulated lipid metabolism, highlighting new directions for prognostic assessment and targeted intervention.

• Cy3 NHS Ester (Non-Sulfonated): Technical Workflow Guide

  2026-06-01

  Cy3 NHS ester (non-sulfonated) addresses the need for robust, high-sensitivity fluorescent labeling of proteins, peptides, and oligonucleotides where organic co-solvents are compatible. It is not suitable for workflows requiring strictly aqueous labeling conditions or for long-term storage of dye solutions. This article provides workflow-specific guidance for maximizing labeling efficiency and data quality.

612 records 12/41 page Previous Next First page 上5页 1112131415 下5页 Last page